Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Biocryst Pharmaceuticals Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 303
- +34 vs. Q4 2025
- Shares held
- 249.3M
- +59.1M (+31.0%) vs. Q4 2025
- Total value
- $2.37B
- +$889.6M (+60.0%) vs. Q4 2025
- New holders
- 75
- 116 more added
- Sold out
- 41
- 76 more reduced
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 15,038,000 | $143.2M | 1.69% | +697,000+4.9% | Added |
| Ra Capital Management, L.P. | 15,827,186 | $150.7M | 1.60% | 00.0% | Unchanged |
| BlackRock, Inc. | 22,650,988 | $215.6M | 0.00% | +1,513,197+7.2% | Added |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −4,089,112−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −2,822,727−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,164,162−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,213,576−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −716,826−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −449,743−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −357,086−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −252,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −190,928−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −114,541−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −108,229−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −105,385−100.0% | Sold out |
| Empire Financial Management Company, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −83,876−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −76,405−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −74,455−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −68,559−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −66,244−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −52,345−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −51,701−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −31,495−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −28,058−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −24,898−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −23,777−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −23,700−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −18,708−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −13,631−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Envestnet Portfolio Solutions, Inc. | 0 | $0 | 0.00% | −10,430−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −6,581−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −692−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Pingora Partners LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |